AMIT MITRA

ASSISTANT PROFESSOR

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Amit Mitra is an Assistant Professor at Auburn University - Harrison School of Pharmacy in the United States. His research focuses on the intersection of pharmacogenomics, drug resistance in cancer treatments, and the effects of COVID-19 on patients with pre-existing conditions. Recent publications include studies on treatment effects related to SARS-CoV-2 vaccination, drug sensitivity in multiple myeloma, and innovative drug prediction methodologies.

Articles (13)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

UNITED STATES

View details

AMARJIT MISHRA

Assistant Professor

Auburn University

UNITED STATES

View details

Qianqian Song

Assistant Professor

Wake Forest School of Medicine

UNITED STATES

View details

Alan Gamis

Section Chief

Children's Medical Research Institute

UNITED STATES

View details

Xueyuan Cao

Associate Professor

University of Tennessee

UNITED STATES

View details

Christopher Cogle

Professor

University of Florida College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

AMIT MITRA

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial–Mesenchymal Transition

Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma

Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer

Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation

Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation

Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative

secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics

<b>The Andrographolide analogue 3A.1 synergizes with Taxane derivatives in aggressive metastatic prostate cancers by upregulation of</b> <b>Heat Shock proteins</b> <b>and downregulation of MAT2A-mediated cell migration and invasion</b>.

Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer.

Short Palate, Lung, and Nasal Epithelial Clone1 (SPLUNC1) level determines steroid-resistant airway inflammation in aging.

Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation.

Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C).

In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma.

Collaborators (10)

Jing Su

Panagiotis Mistriotis

Feifan Liu

Li Chen

Robert D. Arnold

AMARJIT MISHRA

Qianqian Song

Alan Gamis

Xueyuan Cao

Christopher Cogle

Make your next move.